Of polypharmacy and voids: pharmacotherapy in borderline personality disorder
Authors:
- Sergio Armando Covarrubias-CastilloSCSergio Armando Covarrubias-Castillo
- Francisco José Barbosa-CamachoFBFrancisco José Barbosa-Camacho
- 13 May 2025
- journal article
- Published by Royal College of Psychiatrists in BJPsych Advances
- Vol. 31 (4) , 223-225
Abstract
SUMMARY: Despite being the most prevalent personality disorder, borderline personality disorder remains a diagnosis with many unanswered questions, particularly concerning pharmacological management. Although many clinical practice guidelines suggest not prescribing medication unless there are significant clinical comorbidities, it is one of the psychiatric diagnoses with the highest rates of polypharmacy. This commentary on a BJPsych Advances article aims to raise clinical questions regarding the voids of knowledge and the appropriateness of medicating and, perhaps, overmedicating in this particular group.Keywords
This publication has 7 references indexed in Scilit:
- Pharmacological management of personality disorders: from evidence to practiceBJPsych Advances, 2024
- Polypharmacy in the treatment of people diagnosed with borderline personality disorder: repeated cross-sectional study using New Zealand's national databasesBJPsych Open, 2023
- Pharmacological Management of Borderline Personality Disorder and Common ComorbiditiesCNS Drugs, 2023
- “Skills for pills”: The dialectical‐behavioural therapy skills training reduces polypharmacy in borderline personality disorderActa Psychiatrica Scandinavica, 2022
- Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelinesInternational Journal of Psychiatry in Clinical Practice, 2019
- Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disordersEuropean Neuropsychopharmacology, 2015
- A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelinesInternational Clinical Psychopharmacology, 2010